Your browser doesn't support javascript.
loading
Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476).
James, Nicholas D; Clarke, Noel W; Cook, Adrian; Ali, Adnan; Hoyle, Alex P; Attard, Gerhardt; Brawley, Christopher D; Chowdhury, Simon; Cross, William R; Dearnaley, David P; de Bono, Johann S; Diaz-Montana, Carlos; Gilbert, Duncan; Gillessen, Silke; Gilson, Clare; Jones, Rob J; Langley, Ruth E; Malik, Zafar I; Matheson, David J; Millman, Robin; Parker, Chris C; Pugh, Cheryl; Rush, Hannah; Russell, J Martin; Berthold, Dominik R; Buckner, Michelle L; Mason, Malcolm D; Ritchie, Alastair W S; Birtle, Alison J; Brock, Susannah J; Das, Prantik; Ford, Dan; Gale, Joanna; Grant, Warren; Gray, Emma K; Hoskin, Peter; Khan, Mohammad M; Manetta, Caroline; McPhail, Neil J; O'Sullivan, Joe M; Parikh, Omi; Perna, Carla; Pezaro, Carmel J; Protheroe, Andrew S; Robinson, Angus J; Rudman, Sarah M; Sheehan, Denise J; Srihari, Narayanan N; Syndikus, Isabel; Tanguay, Jacob S.
Afiliación
  • James ND; Institute of Cancer Research, London, UK.
  • Clarke NW; The Departments of Surgery & Urology, The Christie & Salford Royal Hospitals, Manchester, UK.
  • Cook A; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, UCL, London, UK.
  • Ali A; The Christie NHS Foundation Trust, Manchester, UK.
  • Hoyle AP; Salford Royal HS Foundation Trust, Manchester, UK.
  • Attard G; UCL Cancer Institute, University College London, London, UK.
  • Brawley CD; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, UCL, London, UK.
  • Chowdhury S; Guy's, King's, & St. Thomas' Hospitals, and Sarah Cannon Research Institute, London, UK.
  • Cross WR; St James University Hospital, Leeds, UK.
  • Dearnaley DP; The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK.
  • de Bono JS; Institute of Cancer Research, London, UK.
  • Diaz-Montana C; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, UCL, London, UK.
  • Gilbert D; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, UCL, London, UK.
  • Gillessen S; Istituto Oncologico della Svizzera Italiana, Bellinzona, Switzerland.
  • Gilson C; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, UCL, London, UK.
  • Jones RJ; Royal Marsden Hospital, London, UK.
  • Langley RE; Beatson West of Scotland Cancer Centre, University of Glasgow, Glasgow, UK.
  • Malik ZI; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, UCL, London, UK.
  • Matheson DJ; Radiotherapy Unit, The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, Liverpool, L7 8YA, UK.
  • Millman R; School of Allied Health and Midwifery, Faculty of Education, Health and Wellbeing, University of Wolverhampton, Wolverhampton, WS1 3BD, UK.
  • Parker CC; (PPI) c/o MRC CTU at UCL, London, UK.
  • Pugh C; Uro-Oncology Unit, Royal Marsden Hospital and Institute of Cancer Research, Sutton, UK.
  • Rush H; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, UCL, London, UK.
  • Russell JM; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, UCL, London, UK.
  • Berthold DR; Guys and St Thomas' NHS Foundation Trust, London, UK.
  • Buckner ML; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
  • Mason MD; Beatson West of Scotland Cancer Centre, Glasgow, UK.
  • Ritchie AWS; Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
  • Birtle AJ; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, UCL, London, UK.
  • Brock SJ; Cardiff University, School of Medicine, Cardiff, UK.
  • Das P; Gloucestershire Hospitals NHS Foundation Trust, Gloucester, UK.
  • Ford D; Rosemere Cancer Centre, Lancashire Teaching Hospitals & University of Manchester, University of Central Lancashire, Lancashire, UK.
  • Gale J; University Hospital Dorset, Bournemouth, UK.
  • Grant W; Department of Oncology, University Hospitals of Derby and Burton NHS Foundation Trust, Derby, UK.
  • Gray EK; City Hospital, Cancer Centre at Queen Elizabeth Hospital, Birmingham, UK.
  • Hoskin P; Portsmouth Hospitals University Trust, Portsmouth, UK.
  • Khan MM; Gloucestershire Oncology Centre, Cheltenham General Hospital, Cheltenham, UK.
  • Manetta C; Musgrove Park Hospital, Taunton, UK.
  • McPhail NJ; Mount Vernon Cancer Centre, Northwood, UK.
  • O'Sullivan JM; Department of Oncology Castle Hill Hospital, Hull, UK.
  • Parikh O; Scarborough General Hospital, Scarborough, UK.
  • Perna C; Brighton and Sussex University Hospitals NHS Trust, Brighton, UK.
  • Pezaro CJ; Department of Clinical Oncology, Raigmore Hospital, Inverness, UK.
  • Protheroe AS; Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK.
  • Robinson AJ; Rosemere Cancer Centre, Lancashire Teaching Hospitals NHS Trust, Preston, UK.
  • Rudman SM; Royal Surrey NHS Foundation Trust, Guildford, UK.
  • Sheehan DJ; Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
  • Srihari NN; Oxford University Hospitals NHS Foundation Trust, Oxfordshire, UK.
  • Syndikus I; Sussex Cancer Centre, Brighton, UK.
  • Tanguay JS; Guys and St Thomas' NHS Foundation Trust, London, UK.
Int J Cancer ; 151(3): 422-434, 2022 08 01.
Article en En | MEDLINE | ID: mdl-35411939
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Neoplasias de la Próstata Resistentes a la Castración Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Humans / Male Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Neoplasias de la Próstata Resistentes a la Castración Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Humans / Male Idioma: En Año: 2022 Tipo del documento: Article